Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Valentina Giardini, Sara Allievi, Carla Fornari, Roberta Rovelli, Giancarlo Cesana, Alessandra Lafranconi & Patrizia Vergani. (2021) Management of pregnancy blood pressure increase in the emergency room: role of PlGF-based biochemical markers and relative economic impact. The Journal of Maternal-Fetal & Neonatal Medicine 34:7, pages 1083-1090.
Read now
Read now
Articles from other publishers (10)
Frederic Chantraine, Kristel Van Calsteren, Roland Devlieger, Damien Gruson, Joachim Van Keirsbilck, Ana Dubon Garcia, Katleen Vandeweyer & Leonardo Gucciardo. (2021) Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers’ perspective. Pregnancy Hypertension 26, pages 31-37.
Crossref
Crossref
Liona C. Poon, Laura A. Magee, Stefan Verlohren, Andrew Shennan, Peter Dadelszen, Eyal Sheiner, Eran Hadar, Gerard Visser, Fabricio Da Silva Costa, Anil Kapur, Fionnuala McAuliffe, Amala Nazareth, Muna Tahlak, Anne B. Kihara, Hema Divakar, H. David McIntyre, Vincenzo Berghella, Huixia Yang, Roberto Romero, Kypros H. Nicolaides, Nir Melamed & Moshe Hod. (2021) A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia. International Journal of Gynecology & Obstetrics 154:S1, pages 3-31.
Crossref
Crossref
Dietmar Schlembach, Martin Hund, Cyrill Wolf & Manu Vatish. (2019) Diagnostic utility of angiogenic biomarkers in pregnant women with suspected preeclampsia: A health economics review. Pregnancy Hypertension 17, pages 28-35.
Crossref
Crossref
M.a José Alcaine Villarroya, Eva M. Barrenechea Iparraguirre, Elena Casals, Concepción González Rodríguez, Inmaculada Martín Navas, Hada Macher Manzano, M. Concepción Martínez Camarasa, Daniel Morell García, Helena Méndez Sol, Irene Rosas Allende, Elvira Tejedor Hernández & Belén Prieto García. (2019) Utilidad de los marcadores bioquímicos de preeclampsia. Revista del Laboratorio Clínico 12:3, pages e9-e24.
Crossref
Crossref
Dietmar Schlembach, Martin Hund, Annabel Schroer & Cyrill Wolf. (2018) Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany. BMC Health Services Research 18:1.
Crossref
Crossref
Mario Plebani. (2018) Quality and future of clinical laboratories: the Vico’s whole cyclical theory of the recurring cycles. Clinical Chemistry and Laboratory Medicine (CCLM) 56:6, pages 901-908.
Crossref
Crossref
Linda J. E. Meertens, Hubertina C. J. Scheepers, Jessica P. M. M. Willemse, Marc E. A. Spaanderman & Luc J. M. Smits. (2018) Should women be advised to use calcium supplements during pregnancy? A decision analysis. Maternal & Child Nutrition 14:1, pages e12479.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Suzy Duckworth, Lucy C. Chappell, Paul T. Seed, Lucy Mackillop, Andrew H. Shennan & Rachael Hunter. (2016) Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks’ Gestation: A Budget Impact Analysis. PLOS ONE 11:10, pages e0164276.
Crossref
Crossref
Arvind Goel & Sarosh Rana. (2013) Angiogenic factors in preeclampsia. Current Opinion in Nephrology & Hypertension 22:6, pages 643-650.
Crossref
Crossref